NBP
NovaBridge Biosciences
1.40$
-0.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
NovaBridge Biosciences (NBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -252 | -281 | -868 | 434 | -973 | -1,103 | -73 | -384 | -21 | |
| 1.6 | 6.7 | 16 | 23 | 34 | 64 | 1.1 | 7.1 | 0.9 | |
| 7.0 | 3.5 | 367 | 493 | 609 | 357 | 10 | -14 | 6.0 | |
| 25 | 147 | 185 | -241 | 395 | 552 | -37 | -21 | 17 | |
| 20 | 14 | 12 | 8.0 | 30 | 46 | 0.2 | 0.4 | 0.0 | |
| -158 | 9.5 | 212 | -202 | -727 | 458 | -108 | -992 | 105 | |
| – | – | 5.3 | – | – | – | – | – | – | |
| – | – | – | -5.3 | 0.0 | -3.1 | -8.7 | -2.4 | 0.0 | |
| – | – | – | – | 0.0 | 2.7 | 9.9 | – | – | |
| 759 | 1,480 | 153 | 3,440 | 594 | 42 | -8.3 | -2.4 | 58 | |
| 349 | 1,268 | -488 | 3,565 | -1,235 | -213 | -152 | -1,706 | 142 | |
| -272 | -295 | -880 | 426 | -1,003 | -1,149 | -73 | -385 | -21 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.